20,000 ivermectin capsules seized at NAIA - BOC | Inquirer News

20,000 ivermectin capsules seized at NAIA – BOC

/ 10:15 AM May 06, 2021

DOH, FDA to endorse reports of invalid ivermectin prescriptions to PRC

INQUIRER.net stock photo

MANILA, Philippines — The Bureau of Customs (BOC) on Thursday reported that it seized a shipment with some 20,000 misdeclared ivermectin tablets along with other drugs from New Delhi, India at the Ninoy Aquino International Airport (NAIA).

The BOC-NAIA, in a statement, said importer Finstad Inc. declared the said shipment as “food supplements, multivitamins, and multi mineral capsules.”


The drugs, the BOC said, were concealed beneath the declared items of the shipment.


The Food and Drug Administration (FDA) currently prohibits the sale of the anti parasitic drug — touted as a cure for COVID-19.

The BOC statement also cited the FDA’s stand on ivermectin.

“At present, the drug is under compassionate use in Specialized Institutions authorized by FDA through the issuance of Compassionate Special permit (CSP),” the BOC quoted  FDA Director Jesusa Joyce Cirunay as saying.

“In case ivermectin has been granted authorization, a valid License to Operate (LTO) as Drug Importer and Emergency Use Authorization (EUA) or Certificate of Product Registration (CPR) shall be presented,” Cirunay added.

For its part, BOC stressed that while they are committed to expedite the processing and release of COVID-19 vaccines, drugs and other medical supplies, they would be “vigilant and further strengthen border security and protection efforts to curb all smuggling attempts to import unregistered, undeclared goods and/or misdeclared goods without the necessary clearance and permits from FDA.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Customs, FDA, Ivermectin

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.